US Patent Issued to Cedars-Sinai Medical Center on July 7 for "RIPK2 inhibition for the treatment of cancer" (California Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,057, issued on July 7, was assigned to Cedars-Sinai Medical Center (Los Angeles).

"RIPK2 inhibition for the treatment of cancer" was invented by Wei Yang (Studio City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are treatments and patient selection methods for cancers such as prostate cancer, breast cancer, liver cancer, bladder cancer, and melanoma. The treatment involves administering a RIPK2 inhibitor to a subject. The patient selection involves selecting a patient who has increased copy numbers or expression of both RIPK2 and MYC."

The patent was filed on March 29, 2021, under Application No. 17/913,760.

*For further ...